Budd-Chiari syndrome epidemiology and demographics: Difference between revisions
Mazia Fatima (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
== Overview == | == Overview == | ||
In 2009-2013, the [[prevalence]] of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea. Budd-Chiari syndrome is a [[Rare diseases|rare disease]]. The [[incidence]] of [[Budd-Chiari syndrome]] was estimated to be about 1 case per million population per year 100,000 individuals in Sweden. The [[Case fatality rate|annual case fatality rate]] of Budd-Chiari syndrome is approximately 2.8%. Budd-Chiari syndrome commonly presents in the third or fourth decade of life. The median age at diagnosis is 51 years. Budd-Chiari syndrome is [[rare]] in [[children]]. [[Females]] are more commonly affected with Budd-Chiari syndrome than [[males]]. The female-to-male ratio is approximately 1.8 to 1. Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders.Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia. | In 2009-2013, the [[prevalence]] of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea. Budd-Chiari syndrome is a [[Rare diseases|rare disease]]. The [[incidence]] of [[Budd-Chiari syndrome]] was estimated to be about 1 case per million population per year 100,000 individuals in Sweden. The [[Case fatality rate|annual case fatality rate]] of Budd-Chiari syndrome is approximately 2.8%. Budd-Chiari syndrome commonly presents in the third or fourth decade of life. The median age at diagnosis is 51 years. Budd-Chiari syndrome is [[rare]] in [[children]]. [[Females]] are more commonly affected with Budd-Chiari syndrome than [[males]]. The female-to-male ratio is approximately 1.8 to 1. Budd-Chiari syndrome in the [[United States]] is predominantly seen in [[women]] and is commonly associated with hematologic disorders. [[Congenital]] membranous forms is the most common cause of [[Budd-Chiari syndrome]] worldwide and particularly in Asia. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
| Line 17: | Line 17: | ||
===Age=== | ===Age=== | ||
*Budd-Chiari syndrome commonly presents in the third or fourth decade of life. | *Budd-Chiari syndrome commonly presents in the third or fourth decade of life. | ||
*The median age at diagnosis is 51 years. | *The median age at [[diagnosis]] is 51 years. | ||
*Budd-Chiari syndrome is rare in children. | *Budd-Chiari syndrome is rare in [[children]]. | ||
===Gender=== | ===Gender=== | ||
*[[Females]] are more commonly affected with Budd-Chiari syndrome than [[males]]. The female-to-male ratio is approximately 1.8 to 1. | *[[Females]] are more commonly affected with Budd-Chiari syndrome than [[males]]. The female-to-male ratio is approximately 1.8 to 1. | ||
Revision as of 20:24, 13 November 2017
|
Budd-Chiari syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Budd-Chiari syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Budd-Chiari syndrome epidemiology and demographics |
|
Budd-Chiari syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Budd-Chiari syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
In 2009-2013, the prevalence of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea. Budd-Chiari syndrome is a rare disease. The incidence of Budd-Chiari syndrome was estimated to be about 1 case per million population per year 100,000 individuals in Sweden. The annual case fatality rate of Budd-Chiari syndrome is approximately 2.8%. Budd-Chiari syndrome commonly presents in the third or fourth decade of life. The median age at diagnosis is 51 years. Budd-Chiari syndrome is rare in children. Females are more commonly affected with Budd-Chiari syndrome than males. The female-to-male ratio is approximately 1.8 to 1. Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders. Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.
Epidemiology and Demographics
The Epidemiology and Demographics of Budd-Chiari syndrome are as follows:[1][2]
Prevalence
- In 2009-2013, the prevalence of Budd-Chiari syndrome was estimated to be 424 patients cases per 5.29 per million (100,000) individuals in South Korea.
Incidence
- Budd-Chiari syndrome is a rare disease.
- The incidence of Budd-Chiari syndrome was estimated to be about 1 case per million population per year 100,000 individuals in Sweden.
Case Fatality Rate
- The annual case fatality rate of Budd-Chiari syndrome is approximately 2.8%.
Age
- Budd-Chiari syndrome commonly presents in the third or fourth decade of life.
- The median age at diagnosis is 51 years.
- Budd-Chiari syndrome is rare in children.
Gender
- Females are more commonly affected with Budd-Chiari syndrome than males. The female-to-male ratio is approximately 1.8 to 1.
Developed Countries
- Budd-Chiari syndrome in the United States is predominantly seen in women and is commonly associated with hematologic disorders.
Developing Countries
- Congenital membranous forms is the most common cause of Budd-Chiari syndrome worldwide and particularly in Asia.
References
- ↑ Ki M, Choi HY, Kim KA, Kim BH, Jang ES, Jeong SH (2016). "Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study". Liver Int. 36 (7): 1067–73. doi:10.1111/liv.13008. PMID 26558363.
- ↑ Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH (2009). "Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience". Liver Int. 29 (2): 253–9. doi:10.1111/j.1478-3231.2008.01838.x. PMID 18694401.